Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07231003

The Effect of Glucomannan Powder on Improving Gut Microbiota.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Taipei Medical University · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The object of this study is evaluating the effects of the Glucommanan on the healthy human subjects who are. In this trial, at most 30 healthy subjects whose ages are 20\~65 years old (15 for placebo and 15 for intervention)will be included. The total experiment will be 9 weeks and the intervention period will be 6 weeks, within which, at week 0, 6, and 7, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), aspartate aminotransferase (AST, also known as GOT), alanine aminotransferase (ALT, also known as GPT), blood urea nitrogen (BUN), serum creatinine (Cr), fasting blood glucose (Glucose, AC) and adiponectin would be measured. Feces samples and anthropometric data will also be acquired. The results will be analyzed according to the methods published by the Ministry of Health and Welfare of Taiwan Food and Drug Administration.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGlucomannan2 packs of glucomannan, 2 grams per pack
DIETARY_SUPPLEMENTPlacebo2 packs of corn starch, 2 grams per pack

Timeline

Start date
2025-08-28
Primary completion
2026-08-31
Completion
2026-12-31
First posted
2025-11-17
Last updated
2025-11-17

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07231003. Inclusion in this directory is not an endorsement.